Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Salomone

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|June 6, 2020
Editorial: New Paradigms in Neuroscience and Related Targets for Drug DiscoverySalvatore Salomone
Frontiers in Pharmacology|June 21, 2011
Pleiotropic effects of glitazones: a double edge sword?Salvatore Salomone
Frontiers in Pharmacology|July 8, 2011
Analytical and experimental pharmacology, challenges aheadSalvatore Salomone
Frontiers in Pharmacology|February 19, 2015
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapyThéophile Godfraind, Salvatore Salomone
Frontiers in Pharmacology|March 17, 2022
Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021Andres Trostchansky, Salvatore Salomone
Frontiers in Pharmacology|June 21, 2011
Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effectsSalvatore Salomone, Christian Waeber
Current Molecular Pharmacology|November 30, 2011
Effects of PPARγ ligands on vascular toneSalvatore Salomone, Filippo Drago
The Open Neurology Journal|November 6, 2009
Migraine: an overviewSalvatore Salomone, Filippo Caraci, Anna Capasso
Frontiers in Pharmacology|November 6, 2012
Ocular drug delivery: a clue from nanotechnologyClaudio Bucolo, Filippo Drago, Salvatore Salomone
Drug News & Perspectives|August 31, 2004
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptorsChristian Waeber, Nicolas Blondeau, Salvatore Salomone
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|June 6, 2020
Editorial: New Paradigms in Neuroscience and Related Targets for Drug DiscoverySalvatore Salomone
Frontiers in Pharmacology|June 21, 2011
Pleiotropic effects of glitazones: a double edge sword?Salvatore Salomone
Frontiers in Pharmacology|July 8, 2011
Analytical and experimental pharmacology, challenges aheadSalvatore Salomone
Frontiers in Pharmacology|February 19, 2015
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapyThéophile Godfraind, Salvatore Salomone
Frontiers in Pharmacology|March 17, 2022
Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021Andres Trostchansky, Salvatore Salomone
Frontiers in Pharmacology|June 21, 2011
Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effectsSalvatore Salomone, Christian Waeber
Current Molecular Pharmacology|November 30, 2011
Effects of PPARγ ligands on vascular toneSalvatore Salomone, Filippo Drago
The Open Neurology Journal|November 6, 2009
Migraine: an overviewSalvatore Salomone, Filippo Caraci, Anna Capasso
Frontiers in Pharmacology|November 6, 2012
Ocular drug delivery: a clue from nanotechnologyClaudio Bucolo, Filippo Drago, Salvatore Salomone
Drug News & Perspectives|August 31, 2004
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptorsChristian Waeber, Nicolas Blondeau, Salvatore Salomone
Pageof 13